The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding .
Notice of Funding Opportunities
Title Announcement Number
Activity Code
Clinical Trials Status Expiration Date
Sort ascending
Program Official
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices RFA-EB-22-002 (R18 Clinical Trial Not Allowed)
R18
Clinical Trial Not Allowed
06/18/2025
Rachel Altshuler, Ph.D.
Discovery and Development of Natural Products for Cancer Interception and Prevention RFA-CA-23-028 (UG3/UH3 Clinical Trial Not Allowed)
UH3, UG3
Clinical Trial Not Allowed
06/14/2025
Altaf Mohammed, Ph.D.
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices RFA-NS-23-028 (RM1 Clinical Trial Optional)
RM1
Clinical Trial Optional
06/10/2025
Rachel Altshuler, Ph.D.
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices RFA-NS-23-003 (RM1 Clinical Trial Optional)
RM1
Clinical Trial Optional
06/10/2025
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research PAR-22-099 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
05/08/2025
Richard Mazurchuk, Ph.D.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-22-174 (U34 Clinical Trials Optional)
U34
05/08/2025
Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-22-173 (R34 Clinical Trials Optional)
R34
05/08/2025
Brandy Heckman-Stoddard, Ph.D., M.P.H.
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) NOT-OD-22-202
Clinical Trial Not Allowed
04/16/2025
Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions RFA-NS-24-021 (R01 - Clinical Trial Optional)
R01
Clinical Trial Optional
02/07/2025
Rachel Altshuler, Ph.D.
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) PAR-22-114
Clinical Trial Optional
01/24/2025
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
